Flamingo Therapeutics is a startup based in the United States, most recent round Series B, 1 tracked investor.
Based in the United States, Flamingo Therapeutics is a startup founded in 2018. Its most recent tracked round is Series B. Brouky records 1 investor associated with the company.
Flamingo Therapeutics is a clinical-stage biotechnology company developing small molecule and oligonucleotide therapies that target long non-coding RNAs (lncRNAs) to treat various cancers.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.